Aggregation pattern and factorial analysis of cardiovascular risk factors included in the metabolic syndrome in a Spanish non-diabetic population : the VIVA study *

131 Abstract Aims: The aim of this study is to describe the most frequent cardiovascular risk factors (CVRF) clustering related to the metabolic syndrome (MS) in a non-diabetic Spanish population sample. Test by factorial analysis if the CVRF in the MS can be considered manifestations of a unique common factor. Materials and methods: Observational, multicenter, transversal epidemiologic study. 2583 subjects aged 3065 were randomly assigned from nine population registries. Exclusive aggregations were considered. Correlation among the MS variables was analyzed using factorial analysis. Results: In order of frequency the prevalence of conventional CVRF was: dyslipidemia: 34% (CI95%: 32-35.5); hypertension: 32% (CI95%: 30.2-33.8); obesity: 27% (CI95%: 25.3-28.7); hyperglycaemia: 23% (CI95%: 21.6-25). 22% of the population showed 2 CVRF and 11% 3 CVRF. The most common CVRF aggregations were hypertension-obesity (5.3%; CI95%: 4.4-6.2) and hypertension-obesity-hyperglycaemia (4.1%; CI95%: 3.3-5). MS specific risk variables tended to aggregate in three factors: factor 1 (BMI, waist circumference and basal glycaemia), factor 2 (insulin, glycaemia 2h, and arterial blood pressure), factor 3 (total cholesterol/HDL, triglycerides). Conclusions: There is a high prevalence of CVRF and MS in the population studied. Analysis of the metabolic syndrome does not contribute with additional information to predict cardiovascular risk in susceptible patients, as compared to the clustering of CVRF. Factorial analysis do not confirm the existence of a unifying factor to explain MS.

[1]  R. Eckel,et al.  Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.

[2]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[3]  M. A. Royo-Bordonada,et al.  Riesgos asociados a la dieta occidental y al sedentarismo: la epidemia de obesidad , 2006 .

[4]  Vera Regitz-Zagrosek,et al.  Gender differences in the metabolic syndrome and their role for cardiovascular disease , 2006, Clinical Research in Cardiology.

[5]  V. Fuster,et al.  MDGs: chronic diseases are not on the agenda , 2005, The Lancet.

[6]  E. Alegrı́a,et al.  Prevalencia del síndrome metabólico en población laboral española: registro MESYAS , 2005 .

[7]  M. J. Medrano,et al.  Factores de riesgo cardiovascular en la población española: metaanálisis de estudios transversales , 2005 .

[8]  A. Biggeri,et al.  Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. , 2004, Diabetes care.

[9]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[10]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[11]  L. Majem,et al.  Prevalencia de la obesidad en España: resultados del estudio SEEDO 2000 , 2003 .

[12]  P. Nilsson,et al.  Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. , 2002, Diabetes & metabolism.

[13]  W. Dietz,et al.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.

[14]  K. Matthews,et al.  Changes in Cardiovascular Risk Factors During the Perimenopause and Postmenopause and Carotid Artery Atherosclerosis in Healthy Women , 2001, Stroke.

[15]  P. Poulsen,et al.  Genetic versus environmental aetiology of the metabolic syndrome among male and female twins , 2001, Diabetologia.

[16]  P. Wahl,et al.  Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. , 2000, American journal of epidemiology.

[17]  S. Grundy,et al.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.

[18]  PäiviLempiäinen,et al.  Insulin Resistance Syndrome Predicts Coronary Heart Disease Events in Elderly Nondiabetic Men , 1999 .

[19]  Ralph B D'Agostino,et al.  Risk Variable Clustering in the Insulin Resistance Syndrome: The Framingham Offspring Study , 1997, Diabetes.

[20]  Alan D. Lopez,et al.  Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study , 1997, The Lancet.

[21]  I Cikes,et al.  [Prevention of coronary heart disease in clinical practice]. , 1996, Lijecnicki vjesnik.

[22]  L. Guize,et al.  Menopause-related changes in lipoproteins and some other cardiovascular risk factors. , 1990, International journal of epidemiology.

[23]  M. Chaparro Prevalencia de factores de riesgo vascular en la población laboral española. , 2006 .

[24]  J. Marrugat,et al.  Estimacin del riesgo coronario en Espaa mediante la ecuacin de Framingham calibrada , 2003 .

[25]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.